Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persistent Asthma
Clinical trial NCT00189722 · COMPLETED
Trial details
- NCT number
- NCT00189722
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Primary completion
- 2005-07-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.